Epigenetic Downregulation of Mitogen-Activated Protein Kinase Phosphatase MKP-2 Relieves Its Growth Suppressive Activity in Glioma Cells
Authors:
- Jörg FelsbergJFJörg Felsberg
- Wolfgang HartmannWHWolfgang Hartmann
- Anna von Dem KnesebeckAKAnna von Dem Knesebeck
- Thomas MikeskaTMThomas Mikeska
- Stefan JoosSJStefan Joos
- Marietta WolterMWMarietta Wolter
- Arend KochAKArend Koch
- Pearlly S. YanPYPearlly S. Yan
- Elmar EndlEEElmar Endl
- Otmar D. WiestlerOWOtmar D. Wiestler
- Guido ReifenbergerGRGuido Reifenberger
Open Access
- 14 February 2010
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (4) , 1689-1699
Abstract
Critical tumor suppression pathways in brain tumors have yet to be fully defined. Along with mutational analyses, genome-wide epigenetic investigations may reveal novel suppressor elements. Using differential methylation hybridization, we identified a CpG-rich region of the promoter of the dual-specificity mitogen-activated protein kinase phosphatase-2 gene (DUSP4/MKP-2) that is hypermethylated in gliomas. In 83 astrocytic gliomas and 5 glioma cell lines examined, hypermethylation of the MKP-2 promoter was found to occur relatively more frequently in diffuse or anaplastic astrocytomas and secondary glioblastomas relative to primary glioblastomas. MKP-2 hypermethylation was associated with mutations in TP53 and IDH1, exclusive of EGFR amplification, and with prolonged survival of patients with primary glioblastoma. Expression analysis established that promoter hypermethylation correlated with reduced expression of MKP-2 mRNA and protein. Consistent with a regulatory role, reversing promoter hypermethylation by treating cells with 5-aza-2′-deoxycytidine increased MKP-2 mRNA levels. Furthermore, we found that glioblastoma cell growth was inhibited by overexpression of exogenous MKP-2. Our findings reveal MKP-2 as a common epigenetically silenced gene in glioma, the inactivation of which may play a significant role in glioma development. Cancer Res; 70(4); 1689–99Keywords
All Related Versions
This publication has 44 references indexed in Scilit:
- An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumorsOncogene, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent DomainsPLOS Genetics, 2008
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Role of mitogen-activated protein kinase phosphatases (MKPs) in cancerCancer and Metastasis Reviews, 2007
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Genetic Pathways to Primary and Secondary GlioblastomaThe American Journal of Pathology, 2007
- Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell linesCancer Genetics and Cytogenetics, 2005
- Abrogation of DUSP6 by hypermethylation in human pancreatic cancerJournal of Human Genetics, 2005
- Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancersOncogene, 2004